Publicaciones en colaboración con investigadores/as de Universidad de Alcalá (33)

2023

  1. Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  2. Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  3. Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019–2021)

    Cancers, Vol. 15, Núm. 6

2021

  1. Downregulation of snail by dusp1 impairs cell migration and invasion through the inactivation of jnk and erk and is useful as a predictive factor in the prognosis of prostate cancer

    Cancers, Vol. 13, Núm. 5, pp. 1-21

  2. The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments

    Cancers, Vol. 13, Núm. 9

2020

  1. Epigenetic regulation of gfi1 in endocrine-related cancers: A role regulating tumor growth

    International Journal of Molecular Sciences, Vol. 21, Núm. 13, pp. 1-12

2017

  1. A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer

    APMIS, Vol. 125, Núm. 9, pp. 787-796

2016

  1. A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy

    Urologia Internationalis, Vol. 97, Núm. 1, pp. 16-25

  2. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

    Molecular Diagnosis and Therapy, Vol. 20, Núm. 6, pp. 531-549

  3. Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile

    Journal of Urology, Vol. 195, Núm. 3, pp. 619-626

  4. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade

    Pathology Research and Practice, Vol. 212, Núm. 10, pp. 899-903

2014

  1. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis

    Prostate, Vol. 74, Núm. 12, pp. 1171-1182

  2. Consenso experto sobre la evidencia científica disponible acerca del uso de toxina botulínica en vejiga hiperactiva

    Actas Urologicas Espanolas, Vol. 38, Núm. 4, pp. 209-216

  3. DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract

    Actas Urologicas Espanolas, Vol. 38, Núm. 9, pp. 600-607

  4. Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism

    Molecular Oncology, Vol. 8, Núm. 1, pp. 27-38

  5. Prostate anatomy in motheaten viable (mev) mice with mutations in the protein tyrosine phosphatase SHP-1

    Actas Urologicas Espanolas, Vol. 38, Núm. 7, pp. 438-444

2013

  1. The study of DNA methylation in urological cancer: Present and future

    Actas Urologicas Espanolas

2012

  1. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway

    Carcinogenesis, Vol. 33, Núm. 6, pp. 1169-1177

2004

  1. Fosfotirosina fosfatasa SHP-1, somatostatina y cáncer de próstata

    Actas Urologicas Espanolas, Vol. 28, Núm. 4, pp. 269-285

2002

  1. Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1

    Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 2, pp. 915-926